Plasmin as a proinflammatory cell activator

Journal of Leukocyte Biology

Volumn 92, Issue 3, 2012, Pages 509-519

  Syrovets, Tatiana ^a   Lunov, Oleg ^a   Simmet, Thomas ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 3; PLASMIN; PLASMINOGEN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BINDING SITE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; FIBRINOGEN DEFECT; FIBRINOLYSIS; FIBROBLAST; HUMAN; HYPOFIBRINOLYSIS; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STAPHYLOCOCCUS INFECTION; TH1 CELL;

ANIMALS; FIBRINOLYSIN; HUMANS; INFLAMMATION; SIGNAL TRANSDUCTION;

EID: 84865511829     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0212056     Document Type: Review

References (108)

1. Booth, N. A., Bachman, F. (2006) Plasminogen-plasmin system. In He-mostasis and Thrombosis: Basic Principles and Clinical Practice (W. Colman, R. J. Marder, V. W. Clowes, A. N. George, J. Z. Goldhaber, eds.), S. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 335-365.
2. Petersen, T. E., Martzen, M. R., Ichinose, A., Davie, E. W. (1990) Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J. Biol. Chem. 265, 6104-6111.
3. Wu, T. P., Padmanabhan, K P., Tulinsky, A. (1994) The structure of recombinant plasminogen kringle 1 and the fibrin binding site. Blood Coagul. Fibrinolysis 5, 157-166.
4. Rios-Steiner, J. L., Schenone, M., Mochalkin, I., Tulinsky, A., Cas-tellino, F. J. (2001) Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein. J. Mol. Biol. 308, 705719.
5. Christen, M. T., Frank, P., Schaller, J., Llinas, M. (2010) Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape. Biochemistry 49, 7131-7150.
6. Mulichak, A. M., Tulinsky, A., Ravichandran, K G. (1991) Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-A resolution. Biochemistry 30, 10576-10588.
7. Battistel, M. D., Grishaev, A., An, S. S., Castellino, F. J., Llinas, M. (2009) Solution structure and functional characterization of human plasminogen kringle 5. Biochemistry 48, 10208-10219.
8. Peisach, E., Wang, J., de los Santos, T., Reich, E., Ringe, D. (1999) Crystal structure of the proenzyme domain of plasminogen. Biochemistry 38, 11180-11188.
9. Ho-Tin-Noe, B., Rojas, G., Vranckx, R., Lijnen, H. R., Angles-Cano, E. (2005) Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis. FEBS J. 272, 3387-3400.
10. Miles, L. A., Dahlberg, C. M., Plow, E. F. (1988) The cell-binding domains of plasminogen and their function in plasma. J. Biol. Chem. 263, 11928-11934.
11. Cesarman-Maus, G., Hajjar, K. A. (2005) Molecular mechanisms of fibrinolysis. Br. J. Haematol. 129, 307-321.
12. Miles, L. A., Hawley, S. B., Baik, N., Andronicos, N. M., Castellino, F. J., Parmer, R. J. (2005) Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Front. Biosci. 10, 1754-1762.
13. Dejouvencel, T., Doeuvre, L., Lacroix, R., Plawinski, L., Dignat-George, F., Lijnen, H. R., Angles-Cano, E. (2010) Fibrinolytic cross-talk: a new mechanism for plasmin formation. Blood 115, 2048-2056.
14. Colman, R. W. (2006) Contact activation (kallikrein-kinin) pathway: multiple physiologic and pathophysiologic activities. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice (W. Colman, R. J. Marder, V. W. Clowes, A. N. George, J. Z. Goldhaber, eds.), S. Lippin-cottWilliams & Wilkins, Philadelphia, PA, USA, 107-130.
15. Gailani, D., Renne, T. (2007) The intrinsic pathway of coagulation: a target for treating thromboembolic disease? J. Thromb. Haemost. 5, 1106-1112.
16. Banbula, A., Zimmerman, T. P., Novokhatny, V. V. (2007) Blood inhibitory capacity toward exogenous plasmin. Blood Coagul. Fibrinolysis 18, 241-246.
17. Marder, V. J., Francis, C. W. (2006) Physiologic regualtion of fibrinolysis. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice (W. Colman, R. J. Marder, V. W. Clowes, A. N. George, J. Z. Goldhaber, eds.), S. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 419436.
18. Lacroix, R., Sabatier, F., Mialhe, A., Basire, A., Pannell, R., Borghi, H., Robert, S., Lamy, E., Plawinski, L., Camoin-Jau, L., Gurewich, V., An-gles-Cano, E., Dignat-George, F. (2007) Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 110, 2432-2439.
19. Weinstein, M. J., Doolittle, R. F. (1972) Differential specificities of the thrombin, plasmin and trypsin with regard to synthetic and natural substrates and inhibitors. Biochim. Biophys. Acta 258, 577-590.
20. Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Bruckner, U. B., Nilsson, B., Gebhard, F., Lambris, J. D., Huber-Lang, M. (2010) Molecular intercommunication between the complement and coagulation systems. J. Immunol. 185, 5628-5636.
21. Hashimoto, K. (2010) Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin. Neurosci. 64, 341-357.
22. Roth, D., Piekarek, M., Paulsson, M., Christ, H., Bloch, W., Krieg, T., Davidson, J. M., Eming, S. A. (2006) Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Am. J. Pathol. 168, 670-684.
23. Heissig, B., Ohki, M., Ishihara, M., Tashiro, Y., Nishida, C., Gritli, I., Rosenkvist, J., Hattori, K (2009) Contribution of the fibrinolytic pathway to hematopoietic regeneration. J. Cell. Physiol. 221, 521-525.
24. Grabowska, M. M., Day, M. L. (2012) Soluble E-cadherin: more than a symptom of disease. Front. Biosci. 17, 1948-1964.
25. Mortier, A., Berghmans, N., Ronsse, I., Grauwen, K., Stegen, S., Van Damme, J., Proost, P. (2011) Biological activity of CXCL8 forms generated by alternative cleavage of the signal peptide or by aminopeptidase-mediated truncation. PLoS One 6, e23913.
26. Syrovets, T., Simmet, T. (2004) Novel aspects and new roles for the serine protease plasmin. Cell. Mol. Life Sci. 61, 873-885.
27. Madureira, P. A., Surette, A. P., Phipps, K D., Taboski, M. A., Miller, V. A., Waisman, D. M. (2011) The role of the annexin A2 heterote-tramer in vascular fibrinolysis. Blood 118, 4789-4797.
28. Herren, T., Swaisgood, C., Plow, E. F. (2003) Regulation of plasminogen receptors. Front. Biosci. 8, D1-D8.
29. Andronicos, N. M., Chen, E. I., Baik, N., Bai, H., Parmer, C. M., Ki-osses, W. B., Kamps, M. P., Yates III, J. R., Parmer, R. J., Miles, L. A. (2010) Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood 115, 1319-1330.
30. Lighvani, S., Baik, N., Diggs, J. E., Khaldoyanidi, S., Parmer, R. J., Miles, L. A. (2011) Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT. Blood 118, 5622-5630.
31. Adams, M. N., Ramachandran, R., Yau, M. K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., Hooper, J. D. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacol. Ther. 130, 248-282.
32. Coughlin, S. R. (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 3, 1800-1814.
33. Quinton, T. M., Kim, S., Derian, C. K, Jin, J., Kunapuli, S. P. (2004) Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4. J. Biol. Chem. 279, 18434-18439.
34. Mao, Y., Jin, J., Daniel, J. L., Kunapuli, S. P. (2009) Regulation of plas-min-induced protease-activated receptor 4 activation in platelets. Platelets 20, 191-198.
35. Gaestel, M., Kotlyarov, A., Kracht, M. (2009) Targeting innate immunity protein kinase signalling in inflammation. Nat. Rev. Drug Discov. 8, 480-499.
36. Gordon, S. (1999) Development and distribution of mononuclear phagocytes: relevance to inflammation. In Inflammation: Basic Principles and Clinical Correlates (I. Gallin, J. Snyderman, R., eds.), Lippincott Williams & Wilkins, Philadelphia, PA, USA, 35-48.
37. Shi, C., Pamer, E. G. (2011) Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11, 762-774.
38. Weber, C., Noels, H. (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17, 1410-1422.
39. Simmet, T., Luck, W. (1989) Clotting of whole human blood induces cysteinyl-leukotriene formation. Thromb. Res. 54, 423-433.
40. Simmet, T., Weide, I. (1991) Thromboxane and cysteinyl-leukotriene formation are differentially activated in spontaneously clotting whole human blood in vitro. Thromb. Res. 62, 249-261.
41. Syrovets, T., Jendrach, M., Rohwedder, A., Schule, A., Simmet, T. (2001) Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKK^-mediated NF-kB activation. Blood 97, 3941-3950.
42. Syrovets, T., Schule, A., Jendrach, M., Buchele, B., Simmet, T. (2002) Ciglitazone inhibits plasmin-induced proinflammatory monocyte activation via modulation of p38 MAP kinase activity. Thromb. Haemost. 88, 274-281.
43. Syrovets, T., Tippler, B., Rieks, M., Simmet, T. (1997) Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway. Blood 89, 4574-4583.
44. Weide, I., Romisch, J., Simmet, T. (1994) Contact activation triggers stimulation of the monocyte 5-lipoxygenase pathway via plasmin. Blood 83, 1941-1951.
45. Weide, I., Simmet, T. (1993) Leukotriene formation by peripheral monocytes in contact-activated human blood. Thromb. Res. 71, 185-192.
46. Weide, I., Simmet, T. (1995) Novel mode of monocyte 5-lipoxygenase stimulation. Adv. Prostaglandin Thromboxane Leukot. Res. 23, 325-327.
47. Weide, I., Simmet, T. (1995) Contact-mediated stimulation of the monocyte 5-lipoxygenase pathway is enhanced by the presence of platelets. Thromb. Res. 77, 187-192.
48. Weide, I., Tippler, B., Syrovets, T., Simmet, T. (1996) Plasmin is a specific stimulus of the 5-lipoxygenase pathway of human peripheral monocytes. Thromb. Haemost. 76, 561-568.
49. Burysek, L., Syrovets, T., Simmet, T. (2002) The serine protease plas-min triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK andjanus kinase (JAK)/STAT signaling pathways. J. Biol. Chem. 277, 33509-33517.
50. Laumonnier, Y., Syrovets, T., Burysek, L., Simmet, T. (2006) Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood 107, 33423349.
51. Tarui, T., Majumdar, M., Miles, L. A., Ruf, W., Takada, Y. (2002) Plas-min-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J. Biol. Chem. 277, 33564-33570.
52. Zhang, Y., Zhou, Z. H., Bugge, T. H., Wahl, L. M. (2007) Urokinase-type plasminogen activator stimulation of monocyte matrix metallopro-teinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin. J. Immunol. 179, 3297-3304.
53. Yona, S., Jung, S. (2010) Monocytes: subsets, origins, fates and functions. Curr. Opin. Hematol. 17, 53-59.
54. Mitchell, J. W., Baik, N., Castellino, F.J., Miles, L. A. (2006) Plasminogen inhibits TNFa-induced apoptosis in monocytes. Blood 107, 43834390.
55. Li, X., Syrovets, T., Genze, F., Pitterle, K., Oberhuber, A., Orend, K. H., Simmet, T. (2010) Plasmin triggers chemotaxis of monocyte-derived dendritic cells through an Akt2-dependent pathway and promotes a T-helper type-1 response. Arterioscler. Thromb. Vasc. Biol. 30, 582-590.
56. Phipps, K D., Surette, A. P., O'Connell, P. A., Waisman, D. M. (2011) Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites. Cancer Res. 71, 6676-6683.
57. Kumar, H., Kawai, T., Akira, S. (2009) Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388, 621-625.
58. Li, Q., Laumonnier, Y., Syrovets, T., Simmet, T. (2007) Plasmin triggers cytokine induction in human monocyte-derived macrophages. Arte-rioscler. Thromb. Vasc. Biol. 27, 1383-1389.
59. Swisher, J. F., Burton, N., Bacot, S. M., Vogel, S. N., Feldman, G. M. (2010) Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood 115, 549-558.
60. Swisher, J. F., Khatri, U., Feldman, G. M. (2007) Annexin A2 is a soluble mediator of macrophage activation. J. Leukoc. Biol. 82, 1174-1184.
61. Ward, J. R., Dower, S. K., Whyte, M. K., Buttle, D.J., Sabroe, I. (2006) Potentiation of TLR4 signalling by plasmin activity. Biochem. Biophys. Res. Commun. 341, 299-303.
62. Buckwalter, M. R., Albert, M. L. (2009) Orchestration of the immune response by dendritic cells. Curr. Biol. 19, R355-R361.
63. Reichel, C. A., Lerchenberger, M., Uhl, B., Rehberg, M., Berberich, N., Zahler, S., Wymann, M. P., Krombach, F. (2011) Plasmin inhibitors prevent leukocyte accumulation and remodeling events in the postisch-emic microvasculature. PLoS One 6, e17229.
64. Lupia, E., Del Sorbo, L., Bergerone, S., Emanuelli, G., Camussi, G., Montrucchio, G. (2003) The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils. Immunology 109, 557-563.
65. Pober, J. S., Sessa, W. C. (2007) Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7, 803-815.
66. He, K L., Sui, G., Xiong, H., Broekman, M. J., Huang, B., Marcus, A. J., Hajjar, K. A. (2011) Feedback regulation of endothelial cell sur face plasmin generation by PKC-dependent phosphorylation of an-nexin A2. J. Biol. Chem. 286, 15428-15439.
67. Chang, W. C., Shi, G. Y., Chow, Y. H., Chang, L. C., Hau, J. S., Lin, M. T., Jen, C. J., Wing, L. Y., Wu, H. L. (1993) Human plasmin induces a receptor-mediated arachidonate release coupled with G proteins in endothelial cells. Am. J. Physiol. 264, C271-C281.
68. Fujiyoshi, T., Hirano, K, Hirano, M., Nishimura, J., Takahashi, S., Ka-naide, H. (2007) Plasmin induces endothelium-dependent nitric oxide-mediated relaxation in the porcine coronary artery. Arterioscler. Thromb. Vasc. Biol. 27, 949-954.
69. Doeuvre, L., Plawinski, L., Goux, D., Vivien, D., Angles-Cano, E. (2010) Plasmin on adherent cells: from microvesiculation to apoptosis. Biochem. J. 432, 365-373.
70. Rautou, P. E., Vion, A. C., Amabile, N., Chironi, G., Simon, A., Tedgui, A., Boulanger, C. M. (2011) Microparticles, vascular function, and atherothrombosis. Circ. Res. 109, 593-606.
71. Nicholl, S. M., Roztocil, E., Galaria, I. I., Davies, M. G. (2005) Plasmin induces smooth muscle cell proliferation. J. Surg. Res. 127, 39-45.
72. Roztocil, E., Nicholl, S. M., Galaria, I. I., Davies, M. G. (2005) Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway. Surgery 138, 180
73. Rossignol, P., Angles-Cano, E., Lijnen, H. R. (2006) Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis. Thromb. Haemost. 96, 665-670.
74. Nurden, A. T. (2011) Platelets, inflammation and tissue regeneration. Thromb. Haemost. 105 (Suppl. 1), S13-S33.
75. Kaminska, B., Gozdz, A., Zawadzka, M., Ellert-Miklaszewska, A., Lipko, M. (2009) MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat. Rec. (Hoboken) 292, 1902-1913.
76. Maeda, S., Nakajima, K, Tohyama, Y., Kohsaka, S. (2009) Characteristic response of astrocytes to plasminogen/plasmin to upregulate transforming growth factor β 3 (TGF^3) production/secretion through proteinase-activated receptor-1 (PAR-1) and the downstream phosphatidyl-inositol 3-kinase (PI3K)-Akt/PKB signaling cascade. Brain Res. 1305, 1-13.
77. Gray, K, Ellis, V. (2008) Activation of pro-BDNF by the pericellular serine protease plasmin. FEBS Lett. 582, 907-910.
78. Baron, A., Hommet, Y., Casse, F., Vivien, D. (2010) Tissue-type plasminogen activator induces plasmin-dependent proteolysis of intracellular neuronal nitric oxide synthase. Biol. Cell 102, 539-547.
79. Niego, B., Freeman, R., Puschmann, T. B., Turnley, A. M., Medcalf, R. L. (2012) t-PA-specific modulation of a human BBB model involves plasmin-mediated activation of the Rho-kinase pathway in astrocytes. Blood, doi:10.1182/blood-2011-07-369512 [Epub ahead of print].
80. Mannaioni, G., Orr, A. G., Hamill, C. E., Yuan, H., Pedone, K H., McCoy, K L., Berlinguer Palmini, R., Junge, C. E., Lee, C. J., Yepes, M., Hepler, J. R., Traynelis, S. F. (2008) Plasmin potentiates synaptic N-methyl-D-aspartate receptor function in hippocampal neurons through activation of protease-activated receptor-1. J. Biol. Chem. 283, 2060020611.
81. Li, Q., Ke, F., Zhang, W., Shen, X., Xu, Q., Wang, H., Yu, X. Z., Leng, Q. (2011) Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice. PLoS One 6, e16483.
82. Szabo, I., Simon Jr., M., Hunyadi, J. (2004) Plasmin promotes keratino-cyte migration and phagocytic-killing accompanied by suppression of cell proliferation which may facilitate re-epithelialization of wound beds. Clin. Dev. Immunol. 11, 233-240.
83. Bauman, K A., Wettlaufer, S. H., Okunishi, K, Vannella, K M., Stool-man, J. S., Huang, S. K., Courey, A. J., White, E. S., Hogaboam, C. M., Simon, R. H., Toews, G. B., Sisson, T. H., Moore, B. B., Peters-Golden, M. (2010) The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. J. Clin. Invest. 120, 1950-1960.
84. Passero, C. J., Mueller, G. M., Rondon-Berrios, H., Tofovic, S. P., Hughey, R. P., Kleyman, T. R. (2008) Plasmin activates epithelial Na+ channels by cleaving the y subunit. J. Biol. Chem. 283, 36586-36591.
85. Svenningsen, P., Friis, U. G., Bistrup, C., Buhl, K B., Jensen, B. L., Skott, O. (2011) Physiological regulation of epithelial sodium channel by proteolysis. Curr. Opin. Nephrol. Hypertens. 20, 529-533.
86. Zhang, G., Kernan, K. A., Collins, S. J., Cai, X., Lopez-Guisa, J. M., Degen, J. L., Shvil, Y., Eddy, A. A. (2007) Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals. J. Am. Soc. Nephrol. 18, 846-859.
87. Kamio, N., Hashizume, H., Nakao, S., Matsushima, K, Sugiya, H. (2008) Plasmin is involved in inflammation via protease-activated receptor-1 activation in human dental pulp. Biochem. Pharmacol. 75, 1974-1980.
88. Okunishi, K, Sisson, T. H., Huang, S. K, Hogaboam, C. M., Simon, R. H., Peters-Golden, M. (2011) Plasmin overcomes resistance to prostaglandin E2 in fibrotic lung fibroblasts by reorganizing protein kinase A signaling. J. Biol. Chem. 286, 32231-32243.
89. Schuster, V., Hugle, B., Tefs, K (2007) Plasminogen deficiency. J. Thromb. Haemost. 5, 2315-2322.
90. Klak, M., Anakkala, N., Wang, W., Lange, S., Jonsson, I. M., Tarkowski, A., Jin, T. (2010) Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis. Scand. J. Infect. Dis. 42, 351-358.
91. De Jong, H. K., van der Poll, T., Wiersinga, W. J. (2010) The systemic pro-inflammatory response in sepsis. J. Innate Immun. 2, 422-430.
92. Guo, Y., Li, J., Hagstrom, E., Ny, T. (2008) Protective effects of plas-min(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. Arthritis Rheum. 58, 764-772.
93. Guo, Y., Li, J., Hagstrom, E., Ny, T. (2011) Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice. PLoS One 6, e24774.
94. Li, J., Guo, Y., Holmdahl, R., Ny, T. (2005) Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. Arthritis Rheum. 52, 2541-2548.
95. Li, J., Ny, A., Leonardsson, G., Nandakumar, K. S., Holmdahl, R., Ny, T. (2005) The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-in-duced arthritis. Am. J. Pathol. 166, 783-792.
96. Hamilton, J. A. (2008) Plasminogen activator/plasmin system in arthritis and inflammation: friend or foe? Arthritis Rheum. 58, 645-648.
97. Renckens, R., Weijer, S., de Vos, A. F., Pater, J. M., Meijers, J. C., Hack, C. E., Levi, M., van der Poll, T. (2004) Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia. Arterioscler. Thromb. Vasc. Biol. 24, 483-488.
98. Min, H. Y., Semnani, R., Mizukami, I. F., Watt, K., Todd III, R. F., Liu, D. Y. (1992) cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J. Immunol. 148, 3636-3642.
99. Andersson, L., Nilsoon, I. M., Colleen, S., Granstrand, B., Melander, B. (1968) Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Ann. N. Y. Acad. Sci. 146, 642-658.
100. Fiechtner, B. K., Nuttall, G. A., Johnson, M. E., Dong, Y., Sujirat-tanawimol, N., Oliver, W. C., Jr., Sarpal, R. S., Oyen, L. J., Ereth, M. H. (2001) Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth. Analg. 92, 1131-1136.
101. Mojcik, C. F., Levy, J. H. (2001) Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann. Thorac. Surg. 71, 745754.
102. Wygrecka, M., Jablonska, E., Guenther, A., Preissner, K. T., Markart, P. (2008) Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thromb. Haemost. 99, 494-501.
103. Swaisgood, C. M., Aronica, M. A., Swaidani, S., Plow, E. F. (2007) Plasminogen is an important regulator in the pathogenesis of a murine model of asthma. Am. J. Respir. Crit. Care Med. 176, 333-342.
104. Leclercq, A., Houard, X., Loyau, S., Philippe, M., Sebbag, U., Meilhac, O., Michel, J. B. (2007) Topology of protease activities reflects athero-thrombotic plaque complexity. Atherosclerosis 191, 1-10.
105. Brands-Nijenhuis, A. V., van Geel, P. P., Meijer, K. (2009) Acute myocardial ischemia in a patient with heterozygous α-2-plasmin inhibitor deficiency. Blood Coagul. Fibrinolysis 20, 599-600.
106. Fay, W. P., Garg, N., Sunkar, M. (2007) Vascular functions of the plasminogen activation system. Arterioscler. Thromb. Vasc. Biol. 27, 12311237.
107. Cozen, A. E., Moriwaki, H., Kremen, M., DeYoung, M. B., Dichek, H. L., Slezicki, K. I., Young, S. G., Veniant, M., Dichek, D. A. (2004) Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death. Circulation 109, 2129-2135.
108. Kuliopulos, A., Covic, L., Seeley, S. K., Sheridan, P. J., Helin, J., Costello, C. E. (1999) Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38, 4572-4585.